Alex S. Baras

1.2k total citations
22 papers, 564 citations indexed

About

Alex S. Baras is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Alex S. Baras has authored 22 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Alex S. Baras's work include Bladder and Urothelial Cancer Treatments (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Urinary and Genital Oncology Studies (4 papers). Alex S. Baras is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Urinary and Genital Oncology Studies (4 papers). Alex S. Baras collaborates with scholars based in United States, Switzerland and Japan. Alex S. Baras's co-authors include Linda Biadasz Clerch, Eric P. Hoffman, Donald Massaro, G. D. Massaro, Thomas Walz, Marlene Dressman, Mihael H. Polymeropoulos, Phillip M. Pierorazio, Max Kates and Trinity J. Bivalacqua and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Human Molecular Genetics.

In The Last Decade

Alex S. Baras

18 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex S. Baras United States 12 214 203 187 91 76 22 564
Georgi Guruli United States 13 154 0.7× 118 0.6× 248 1.3× 112 1.2× 87 1.1× 30 589
Evelina La Civita Italy 15 173 0.8× 243 1.2× 133 0.7× 90 1.0× 148 1.9× 39 574
D. P. S. SANDHU United Kingdom 12 156 0.7× 220 1.1× 64 0.3× 125 1.4× 63 0.8× 22 472
Marie‐Françoise Pelte Switzerland 16 109 0.5× 122 0.6× 193 1.0× 155 1.7× 118 1.6× 24 836
Hiroshi Hongo Japan 13 169 0.8× 274 1.3× 80 0.4× 119 1.3× 108 1.4× 74 511
H. Ballentine Carter United States 9 123 0.6× 268 1.3× 90 0.5× 173 1.9× 66 0.9× 14 544
Jiwen Cheng China 12 360 1.7× 181 0.9× 109 0.6× 152 1.7× 161 2.1× 36 668
Yukie Takimoto Japan 12 235 1.1× 465 2.3× 92 0.5× 143 1.6× 131 1.7× 29 785
Keefe Murphy Ireland 10 147 0.7× 268 1.3× 112 0.6× 151 1.7× 105 1.4× 21 579
Darius Dasevičius Lithuania 15 209 1.0× 62 0.3× 117 0.6× 112 1.2× 123 1.6× 28 547

Countries citing papers authored by Alex S. Baras

Since Specialization
Citations

This map shows the geographic impact of Alex S. Baras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex S. Baras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex S. Baras more than expected).

Fields of papers citing papers by Alex S. Baras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex S. Baras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex S. Baras. The network helps show where Alex S. Baras may publish in the future.

Co-authorship network of co-authors of Alex S. Baras

This figure shows the co-authorship network connecting the top 25 collaborators of Alex S. Baras. A scholar is included among the top collaborators of Alex S. Baras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex S. Baras. Alex S. Baras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deutsch, Julie S., Ashley Cimino‐Mathews, Elizabeth D. Thompson, et al.. (2025). Abstract CT097: Associations between percent residual viable tumor (%RVT) and efficacy with perioperative nivolumab (NIVO) for resectable NSCLC in CheckMate 77T. Cancer Research. 85(8_Supplement_2). CT097–CT097.
2.
Saria, Suchi, Brian Piening, Brendan D. Curti, et al.. (2022). A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy. Cancer Informatics. 21. 2663762641–2663762641. 3 indexed citations
3.
Wake, Laura, Derek B. Allison, Jody E. Hooper, et al.. (2021). Pathology Residency Program Special Expertise Tracks Meet the Needs of an Evolving Field. Academic Pathology. 8. 2466136426–2466136426. 4 indexed citations
4.
Yu, Ruoxi, Deyin Xing, Brigitte M. Ronnett, et al.. (2021). Hot or not: defining trophoblast PD-L1 expression and lymphohistiocytic density in gestational trophoblastic neoplasia. Gynecologic Oncology. 162. S171–S172.
5.
Becker, Russell E.N., Alexa Meyer, Aaron Brant, et al.. (2020). Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. European Urology. 79(3). 364–371. 40 indexed citations
6.
Kates, Max, Thomas R. Nirschl, Alex S. Baras, et al.. (2019). Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer. European Urology Oncology. 4(1). 117–120. 7 indexed citations
7.
Tomasetti, Cristian, Justin Poling, Nicholas J. Roberts, et al.. (2019). Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence. Proceedings of the National Academy of Sciences. 116(41). 20482–20488. 61 indexed citations
8.
Kates, Max, Thomas R. Nirschl, Nikolai A. Sopko, et al.. (2017). Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer. Cancer Immunology Research. 5(7). 594–603. 56 indexed citations
9.
Datta, Sayantan, Hae-Seong Nam, Masamichi Hayashi, et al.. (2017). Expression of GULP1 in bronchial epithelium is associated with the progression of emphysema in chronic obstructive pulmonary disease. Respiratory Medicine. 124. 72–78. 3 indexed citations
10.
Sheikhbahaei, Sara, Christopher S. Jones, Kristin K. Porter, et al.. (2017). Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses. Clinical Nuclear Medicine. 42(4). e188–e193. 25 indexed citations
11.
Rowe, Steven P., Michael A. Gorin, Lilja B. Sólnes, et al.. (2017). Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression. EJNMMI Research. 7(1). 80–80. 41 indexed citations
12.
Brant, Aaron, Max Kates, Meera R. Chappidi, et al.. (2016). Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?. Urologic Oncology Seminars and Original Investigations. 35(1). 34.e17–34.e25. 16 indexed citations
13.
Kates, Max, Mark W. Ball, Meera R. Chappidi, et al.. (2016). Accuracy of urethral frozen section during radical cystectomy for bladder cancer. Urologic Oncology Seminars and Original Investigations. 34(12). 532.e1–532.e6. 9 indexed citations
14.
VandenBussche, Christopher J., et al.. (2013). Inexpensive telecytology solutions that use the Raspberry Pi and the iPhone. Journal of the American Society of Cytopathology. 3(1). 49–55. 25 indexed citations
15.
Loyo, Myriam, Alex S. Baras, & Lee M. Akst. (2013). Plasmacytoma of the larynx. American Journal of Otolaryngology. 34(2). 172–175. 8 indexed citations
16.
Pollard, Courtney, et al.. (2009). Genoproteomic Mining of Urothelial Cancer Suggests γ-Glutamyl Hydrolase and Diazepam-Binding Inhibitor as Putative Urinary Markers of Outcome after Chemotherapy. American Journal Of Pathology. 175(5). 1824–1830. 20 indexed citations
17.
Lee, Monica Y., Sean M. Garvey, Alex S. Baras, et al.. (2009). Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells. Human Molecular Genetics. 19(3). 468–479. 29 indexed citations
18.
Clerch, Linda Biadasz, Alex S. Baras, G. D. Massaro, Eric P. Hoffman, & Donald Massaro. (2004). DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 286(2). L411–L419. 41 indexed citations
19.
Massaro, Donald, G. D. Massaro, Alex S. Baras, Eric P. Hoffman, & Linda Biadasz Clerch. (2004). Calorie-related rapid onset of alveolar loss, regeneration, and changes in mouse lung gene expression. American Journal of Physiology-Lung Cellular and Molecular Physiology. 286(5). L896–L906. 93 indexed citations
20.
Dressman, Marlene, et al.. (2003). Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.. PubMed. 63(9). 2194–9. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026